Quantcast

Industry news that matters to you.  Learn more

Luminex Technology Selected by Assurex Health

Luminex Corporation (NASDAQ: LMNX) recently announced that its xTAG® Technology has been selected for use in enhancing the processing speed and capacity of Assurex Health’s patented GeneSight® tests. 

Extensive Scientific Data Supports the Clinical Validity of Pharmacogenomic Testing for Predicting Patient Response to Psychiatric Medications

AssureRx Health, a leading personalized medicine company, recently announced that the International Review of Psychiatry published an extensive review that validates the clinical use of pharmacogenomic testing to help predict patient response to psychiatric medications and improve treatment outcomes.

AssureRx Health Launches Personalized Medicine Test for ADHD

AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.